Henric Bjorn Bjarke, SVP, COO at Inozyme Pharma, Inc. (INZY), bought 21,500 shares at $1.39 ($30K) on 2022-12-15, disclosed to the SEC on 2022-12-19.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |